<?xml version="1.0" encoding="UTF-8"?>
<ref id="pbi13194-bib-0032">
 <mixed-citation publication-type="journal" id="pbi13194-cit-0032">
  <string-name>
   <surname>Moldt</surname>, 
   <given-names>B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Shibata‐Koyama</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Rakasz</surname>, 
   <given-names>E.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Schultz</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kanda</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Dunlop</surname>, 
   <given-names>D.C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Finstad</surname>, 
   <given-names>S.L.</given-names>
  </string-name>
  <italic>et al</italic> (
  <year>2012</year>) 
  <article-title>A Nonfucosylated Variant of the anti‐HIV‐1 Monoclonal antibody b12 Has enhanced FcγRIIIa‐mediated antiviral activity 
   <italic>in vitro</italic> but does not improve protection against mucosal SHIV challenge in macaques
  </article-title>. 
  <source xml:lang="en">J. Virol.</source>
  <volume>86</volume>, 
  <fpage>6189</fpage>–
  <lpage>6196</lpage>.
  <pub-id pub-id-type="pmid">22457527</pub-id>
 </mixed-citation>
</ref>
